Alzai Health Corp. ALZI.V
TSX
| 01/31/2026 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -- | ||||
| SG&A Expenses | 262.42% | ||||
| Depreciation & Amortization | 3,100.00% | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 409.28% | ||||
| Operating Income | -400.14% | ||||
| Income Before Tax | -394.28% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -394.28% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -394.28% | ||||
| EBIT | -400.14% | ||||
| EBITDA | -400.41% | ||||
| EPS Basic | -85.45% | ||||
| Normalized Basic EPS | -84.06% | ||||
| EPS Diluted | -85.45% | ||||
| Normalized Diluted EPS | -84.06% | ||||
| Average Basic Shares Outstanding | 167.08% | ||||
| Average Diluted Shares Outstanding | 167.08% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||